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Abstract 
 
In 2018, nearly 57% of American adults reported drinking alcohol in the past month, and 
41.5% of current drinkers reported taking alcohol-interactive (AI) medications. Consuming 
alcohol and medications concurrently may result in adverse effects. The purpose of this study 
was to determine the effectiveness of a one-hour lecture about AI medications in a class of 
undergraduate nursing students (N = 48) at a small Midwestern university. The Jarvis Nursing 
Knowledge of Alcohol-Interactive Medications survey was distributed on August 27, 2018, and 
again on November 19, 2018. A significant increase was found between pretest and posttest on 
correct identification of mechanism (27.47 ± 14.18 vs. 37.33 ± 16.60; t =3.15; p < .02). A 
significant increase was also found between pretest and posttest scores on the ability to 
discriminate a medication as AI or Non-AI (68.5% ± 6.3 vs 71.5% ± 6.5; t= 2.5; p <. 02). While 
scores increased significantly, students failed to consistently recognize the correct medication-
alcohol interaction. A one-hour lecture emphasizing AI medications in the pre-licensure program 
enhanced students’ knowledge; however, future research is needed to determine retention of AI 
medication knowledge. 
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Nursing Students' Knowledge of Alcohol - Interactive Medications 
 
Alcohol is one of the most popular and potentially harmful drugs in the United States. More 
than 88,000 people die from alcohol related causes each year, making it the third highest cause of 
preventable death (National Institute on Alcohol Abuse and Alcoholism [NIAAA], 2018). Of 
people aged 18 years or older, 86.4% reported drinking alcohol in their lifetime; 70.1% reported 
drinking in the past year; and 56.0% reported drinking in the past month (NIAAA, 2018). In 
2015, 26.9 % of people ages 18 years or older reported binge drinking in the past month and 7% 
reported heavy alcohol use in the past month. Binge drinking is a pattern of drinking that brings 
blood alcohol concentration (BAC) levels above 0.08 g/dL. Binge drinking is defined as four 
drinks for women and five drinks for men in about two hours. Heavy drinking is defined as binge 
drinking on five or more days in the past month (NIAAA, 2018).  
Alcohol-interactive (AI) medications are any medication with which alcohol interacts on a 
pharmacokinetic (movement through the body) or pharmacodynamic (interaction in cells) level 
to produce additive or antagonistic effects.  Over a 12-year period (1999–2010), an average of 
41.5% of current drinkers 20 years and older reported taking at least one AI prescription 
medication (Breslow et al., 2015). From 2011-2014, 48.9% of adults over 18 years of age used at 
least one prescription medication in the last 30 days (Centers for Disease Control [CDC], 2016). 
People age 65 years and older have a higher prevalence of taking multiple medications, and 
current drinkers, age 65 and older, have a higher prevalence of taking at least one AI prescription 
medication (Breslow et al., 2015; National Center for Health Statistics, 2014). In the U.S. people 
aged 65 years or older ,90.6% reported taking a prescription drug in the last 30 days (CDC, 
2016). Due to age related changes, people aged 65 years and older metabolize alcohol more 
ALCOHOL INTERACTIVE MEDICATIONS 4 
slowly and have less body water compared with younger adults, the bioavailability of alcohol 
increases when consuming the same amount of alcohol as a younger adult (Weathermon & 
Crabb, 1999). Age-related changes in absorption, distribution, and metabolism of alcohol and 
medications, place people aged 65 and older at greater risk for adverse effects of combining 
alcohol and medications (Moore et al., 2007).  
Central nervous system (CNS) agents are among the most common prescription 
medications used across all age groups in the United States. Through pharmacokinetic and 
pharmacodynamic interactions, alcohol interferes with the absorption, distribution, metabolism, 
and excretion of medications and can have additive or antagonistic effects, particularly in the 
CNS (Tanaka, 2003). Within the class of CNS agents, pain relievers were involved in 28.4% of 
the alcohol associated drug interaction emergency department (ED) visits, mainly opioids at 
17.4% (Castle, Dong, Haughwout, & White, 2016). Anti-anxiety drugs, sedatives, and sleep 
medications were involved in 24.7% of the alcohol associated drug interaction ED visits, mainly 
benzodiazepines at 16.7% (Castle et al., 2016).  Within the class of psychotherapeutic agents, 
antidepressants and antipsychotics were involved in 8.6% and 6.1%, respectively, of alcohol 
associated drug interaction ED visits (Castle et al., 2016) 
Education on AI medications is a necessity for nurses, as evidenced by the rise of 
prescription medications and increased use of alcohol in the U.S. Nurses need to be educated on 
AI medication because a vital responsibility of nurses is to be vigilant about health risks and to 
provide health education. In undergraduate nursing schools only 56% of schools offer one to five 
hours of didactic alcohol education, and 30% of schools offer one to five clinical hours of 
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alcohol education (Mollica, Hyman, & Mann, 2011). The education that was identified by 
(Mollica, Hyman, & Mann, 2011) focused on alcohol withdrawal, abuse, and addiction. 
As well as undergraduate students lacking AI medication knowledge, professional 
registered nurses also lack AI medication knowledge. In 2016, professional nurses working at a 
Midwestern Magnet-designated hospital correctly identified AI medication only 56.3% of the 
time (Serafico & Jarvis, 2017). A knowledge gap of AI medications was identified in practicing 
nurses; and therefore important that there is adequate education on AI medication content in 
undergraduate programs. Including AI medication teaching into the curriculum of undergraduate 
nursing programs will help future nurses with the critical knowledge they need to deliver safe 
care to patients. Therefore, the aims of this study are to: 
1. Assess nursing students’ baseline level of knowledge of AI medications. 
2. Determine if a single lecture in the sophomore year pathophysiology and pharmacology 
course is effective in increasing knowledge on AI medication content. 
3. Determine to what extent the Jarvis Nursing Knowledge of AI Medications (JaNKam) 
survey is reliable when administered to nursing students. 
Background 
Literature Review 
From 2000-2018 no published studies addressing the level of undergraduate nursing 
students’ knowledge on alcohol physiology or alcohol interactive medications were found. 
Literature was published regarding undergraduate nursing students’ attitudes towards both 
alcohol abuse and caring for patients admitted for alcohol abuse, nursing students’ knowledge on 
alcoholism, and nursing students’ knowledge on intoxication. 
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Metabolism of Alcohol 
 
Alcohol is absorbed primarily in two places in the human body: the stomach and the 
small intestines. Of those two locations, 20% of alcohol is absorbed by the stomach and 80% is 
absorbed by the intestines (Burcham & Rosenthal, 2018). Meals high in fat, carbohydrates, or 
protein are all equally effective in slowing stomach emptying (Cederbaum, 2012). The small 
intestine’s alcohol absorption is independent of the presence of food (Burcham & Rosenthal, 
2018). The small intestine, however, is dependent on gastric emptying time and as such the rate 
of alcohol absorption is limited by the presence or absence of food in the stomach. Milk is 
particularly effective at slowing gastric emptying, thus delaying alcohol absorption. Alcohol has 
minimal nutritional value, with a caloric value of 7kcal per gram (Cederbaum, 2012). Alcohol is 
different from other nutrients in that it is not stored, instead remaining in the body until excreted. 
(Cederbaum, 2012).  Additionally, alcohol metabolism is not heavily influenced by hormones 
(insulin, glucagon, leptin, catecholamine and thyroid hormone), which is dissimilar to hormonal 
effects on other nutrients (Cederbaum, 2012).  
Alcohol is a unique substance, in that many membranes are permeable to alcohol. 
Alcohol is both lipid and water soluble and thus is distributed to all body tissues and fluids 
quickly after drinking. The blood brain barrier is permeable to alcohol, which allows the drug to 
gain easy access to the CNS and exert its effects. The CNS levels rise rapidly because the brain 
receives a large proportion of the blood flow. Alcohol is a teratogen because the placenta is 
permeable to alcohol, which can lead to fetal abnormalities if alcohol is ingested during 
pregnancy.  
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Several factors, including alcohol usage, sex, and age alter the rate of alcohol 
metabolism. Alcohol is metabolized at a constant rate of 15 ml (0.5 oz) per hour, regardless of 
how much alcohol is ingested. The metabolism of alcohol is unique because despite rising 
plasma drug levels, the rate of the drug’s breakdown is relatively unchanged. The breakdown 
rate equates to one standard drink an hour. A standard drink is defined as one standard can/bottle 
of beer, one 5 oz glass of wine, or one standard shot (30 mL of spirits). When used on a regular 
basis, alcohol induces liver drug metabolizing enzymes, which increase the rate of metabolism. 
Due to the hepatic enzyme induction, chronic drinkers can metabolize the drug faster than people 
who drink moderately (Cederbaum, 2012).  
The activity of the metabolizing enzyme alcohol dehydrogenase (ADH) in the stomach 
differs between males and females. Women have a lesser degree of stomach ADH activity, thus 
decreasing the first pass metabolism (Weathermon & Crabb, 1999). The enzyme ADH catalyzes 
the oxidation of alcohol to aldehydes. The decreased stomach ADH results in decreased first pass 
effect and increased bioavailability, which partly explains why women achieve a higher BAC 
than men after the same quantity of drinks (Burcham & Rosenthal, 2018). The first pass effect is 
defined as the amount of alcohol that is metabolized by ADH before reaching systemic 
circulation. Furthermore, women have a smaller percentage of body water (45%) compared to 
men (about 55%) (Burcham & Rosenthal, 2018). This differing amount of water in fluid 
compartments means less dilution of alcohol, causing an increased concentration in the tissues 
and fluids in women, thereby increasing alcohol’s effects (Burcham & Rosenthal, 2018). Age 
also affects alcohol metabolism. For example, the fetal liver eliminates alcohol poorly which in 
turn leads to fetal alcohol syndrome (Cederbaum, 2012). There is also a small decline in alcohol 
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elimination with older adults, potentially due to decreased liver mass, or decreased water content 
(Cederbaum, 2012).         
The process of metabolism occurs in both the stomach and liver, and starts with the 
conversion of alcohol to acetaldehyde by ADH. Once acetaldehyde is formed, it is converted to 
acetate by aldehyde dehydrogenase (ALDH).  Much of the acetate produced circulates to 
peripheral tissues where it is activated into acetyl CoA (Cederbaum, 2012). After acetate is 
activated into acetyl CoA, it then enters the citric acid cycle. Acetyl CoA is a molecule that 
participates in the citric acid cycle of energy production by delivering an acetyl group.  
Alcohol is metabolized primarily by the enzyme alcohol dehydrogenase. The enzyme 
ADH functions by oxidizing endogenous (alcohols produced by metabolic processes) and 
exogenous (alcohol that is consumed) alcohols. The highest amount of ADH is found in the liver, 
with lesser amounts present in the gastrointestinal (GI) tract, kidneys, and nasal mucosa. As 
much as 90% of alcohol consumed is removed from the body via oxidation by the liver, with the 
remaining 10% of alcohol being directly removed via excretion in breath, sweat, and urine 
(Cederbaum, 2012).  Alcohol oxidation is primarily limited by the maximum capacity of ADH.  
Alcohol is metabolized to a lesser extent by the cytochrome P450 family of enzymes in 
the liver. Cytochrome P450s are a family of enzymes responsible for oxidation of steroids, fatty 
acids. The CYP2E1 is a P450 enzyme that has the highest activity for oxidizing alcohol to 
acetaldehyde (Cederbaum, 2012). As alcohol concentrations increase, CYP2E1enzymes increase 
their involvement in oxidation (Cederbaum, 2012). Importantly, some medications compete for 
metabolism by CYP2E1 enzymes and thus when consumed with alcohol, the metabolism of 
those medications is inhibited. The inhibition of the medication’s metabolism increases their half 
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life, which then results in the drinker experiencing increased sensitivity to the drugs and adverse 
effects of the medication.  The CYP2E1 enzymes are increased in chronic drinkers, and thus, 
when alcohol is not present, medications metabolized by these enzymes will have decreased half-
lives and as a result have less therapeutic effectiveness.  
AI Medications 
Alcohol is a CNS depressant. When alcohol is consumed in combination with other CNS 
depressants (eg., barbiturates, benzodiazepines, opioids), the effects are additive and the CNS 
depression is potentiated. Barbiturates increase cytochrome P450 activity in the liver and 
accelerate alcohol elimination from the blood (Weathermon & Crabb, 1999). An adverse effect 
of opioids is the respiratory depression from the action of these medications as Mu receptor 
agonists (Burchum & Rosenthal, 2018). Opioid medications act at opioid receptors in the 
medulla to suppress the cough reflex which may lead to the accumulation of secretions in the 
airway (Burchum & Rosenthal, 2018). Respiratory depression and suppression of the cough 
reflex is increased by concurrent use of other CNS depressants such as alcohol (Burchum & 
Rosenthal, 2018). Alcohol enhances the effects in the CNS of antihistamines such as drowsiness, 
sedation, and decreased motor skills (Weathermon & Crabb, 1999). The combination of alcohol 
and benzodiazepines alter the psychomotor skills associated with driving, primarily due to a 
potentiated effect on reaction and coordination. Short-acting benzodiazepines without active 
metabolites appear to cause less impairment than longer-acting benzodiazepines (Chan & 
Anderson, 2014). 
Alcohol interacts with Histamine 2 (H2) receptor blockers (drugs that decrease gastric 
acid) by decreasing the first pass metabolism. The presence of H2 receptor blockers such as 
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cimetidine (Tagamet) or ranitidine (Zantac) inhibit stomach ADH activity (Cederbaum, 2012). 
Since stomach ADH activity is inhibited, blood concentrations of alcohol increase. 
Some antibiotics such as isoniazid (Nydrazid, Landiazid) and erythromycin (Erythrocin) 
interact with alcohol. Erythromycin may increase alcohol absorption in the small intestines and 
therefore increase blood alcohol concentrations. Isoniazid can cause liver damage which can be 
exacerbated by alcohol consumption as well.  
Alcohol and NSAIDS (non-steroidal anti-inflammatory drugs) can injure the 
gastrointestinal (GI) mucosa. Alcohol in combination with NSAIDS, including ibuprofen 
(Advil), can cause a significant increase in gastric bleeding. Aspirin (Bayer) has been shown to 
inhibit stomach ADH, therefore decreasing the first pass effect and increasing blood 
concentrations of alcohol (Cederbaum, 2012). Aspirin (Bayer) increases gastric emptying which 
leads to faster absorption by the small intestine (Weathermon & Crabb, 1999). Aspirin (Bayer) , 
indomethacin ( Indocin) , and ibuprofen (Advil) and cause enhanced bleeding when taken in 
conjunction with alcohol (Weathermon & Crabb, 1999). Concurrent alcohol intake at any 
concentration increases the risk of upper gastrointestinal bleeding associated with aspirin. The 
likely explanation for this interaction includes the reversal of the inhibition of vascular 
prostaglandin synthesis by alcohol which promotes bleeding (Chan & Anderson, 2014). 
Alcohol also interacts with anticoagulants, particularly warfarin.  Warfarin (Coumadin) 
acts as an anticoagulant by decreasing production of clotting factors VII, IX, X, and prothrombin 
(Burchum & Rosenthal, 2018). Alcohol acts as an anticoagulant by decreasing platelet 
aggregation, decreasing levels of fibrinogen, and increasing levels of tissue plasminogen 
activator (clot dissolving enzyme) (Burchum & Rosenthal, 2018). The synergistic interaction 
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between warfarin (Coumadin) and alcohol results in higher levels of anticoagulation and thus 
creates a higher risk of hemorrhage. When alcohol is used on a regular basis, it induces hepatic 
drug metabolizing enzymes, thereby increasing the rate of its own metabolism and that of other 
drugs. Warfarin (Coumadin) is inactivated in the liver mainly by CYP2C9, and the 2C9 
isoenzyme of cytochrome P450 (Burchum & Rosenthal, 2018). A person who chronically uses 
alcohol will have decreased anticoagulation effects of warfarin (Coumadin) due to the increased 
metabolism.   
Acetaminophen (Tylenol) and alcohol interact and pose the risk of potentially fatal liver 
damage. There is evidence that two to four standard drinks a day in combination with a high dose 
of acetaminophen (Tylenol) can cause fatal liver damage; thus, 2000 mg of acetaminophen 
(Tylenol) a day is the recommended limit for people who simultaneously consume alcohol 
(Burchum & Rosenthal, 2018). Alcohol enhances acetaminophen (Tylenol) metabolism by 
CYP2E1 into a toxic byproduct potentially causing liver damage (Weathermon & Crabb, 1999). 
It is especially important to educate patients to read labels to see hidden doses of acetaminophen 
(Tyleonol) in medications combined with codeine and oxycodone (Percocet). 
Alcohol elevates blood pressure when used chronically and thus tends to counteract the 
effects of antihypertensive medications. When alcohol was given to 10 healthy male subjects 
after they received multiple doses of the antihypertensive verapamil (Calan), significantly higher 
blood alcohol levels were detected (Chan & Anderson, 2014). Verapamil (Calan) also increased 
the subjects’ perceptions of alcohol intoxication. These are likely the result of inhibition of 
CYP2E1 (Chan & Anderson, 2014). 
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Alcohol and the anti- diabetic medication metformin (Glucophage) interact. Metformin 
inhibits the mitochondrial oxidation of lactic acid and thereby can result in the adverse effect of 
lactic acidosis (Burchum & Rosenthal, 2018). Metformin (Glucophage) may cause an increase in 
lactic acid in the blood after alcohol consumption.  
Methods 
 
Sample  
All 50 second-year nursing students at a Midwestern liberal arts university was asked to 
participate in this study. Of the 50 students that were asked to participate, the final sample 
utilized for data analysis was 48 matched surveys.  The eligibility requirement for this study was 
current enrollment as second-year nursing student in the N217 Pathophysiology and 
Pharmacology course. The study was conducted during the students’ N217 Pathophysiology and 
Pharmacology lecture time. IRB approval was granted from the Illinois Wesleyan University 
IRB. Consent was conferred upon completion of the survey (Appendix A). 
Data Collection 
Data collection occurred at two different points. The data collection consisted of one 
pretest and one posttest. The pretest occurred on August 27th, 2018, the first day of class and 
before the students had received any pharmacology content. The AI medications lecture was 
delivered on November 19, 2018. The posttest was administered December 10, 2018, 21 days 
after the AI medication lecture. Forty-eight students responded to the survey, resulting in a 96% 
response rate. No students were excluded in this study. The final sample size was 48 students.  
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Pedagogical approach to AI medications 
Given the rise in use of AI medications and the lack of professional nurses’ knowledge of 
AI medications (Serafico & Jarvis, 2017), one approach to deliver AI content to undergraduate 
nursing students was explored. A single traditional one-hour lecture was delivered to the N217 
Pathophysiology and Pharmacology class using a power point format. The lecture was delivered 
by the student researcher. The student researcher was a senior level nursing major who had 
successfully completed the N217 course. The lecture was rehearsed three times and reviewed by 
the student researcher’s faculty advisor. The lecture contained information on the metabolism of 
alcohol as well as information on the interactions that alcohol has with several medications. The 
lecture included AI medications that were both on the Jarvis Nursing Knowledge of AI 
Medications (JaNKAM) instrument and medications that were not tested on the JaNKAM. The 
lecture lasted 45 minutes and there were five minutes after to answer questions. The PowerPoint 
slides utilized in the AI medication lecture can be found in Appendix B. 
Instrument  
Knowledge of AI medications was measured by using the JaNKAM Survey, which was 
developed in 2016 (Appendix C). The survey includes questions on 14 of the 25 most commonly 
prescribed medications in the United States, using data from the Centers for Medicare and 
Medicaid Services, the Institute for Healthcare Informatics, and the Centers for Disease Control 
and Prevention (CDC, 2016). There are 14 questions, and for each question there are five 
potential answers.  Each survey question asks the participant to select the correct interaction of 
alcohol and a selected medication from a multiple choice listing. The multiple choices include 
four potential mechanisms alcohol could interact with the given medication as well as a choice 
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that alcohol and the given medication do not interact. The survey includes both the generic and 
the brand names of each drug. The JaNKAM survey tool utilized in this study was changed from 
the tool utilized in Serafico and Jarvis, 2017. The 2017 tool had an alpha of (α = 0.628). 
Data Analysis  
Data analysis was conducted using IBM SPSS Statistics (version 25). Descriptive 
statistics were used to describe demographic characteristics. Inferential statistics were used to 
score the accuracy of participants’ answers to the JaNKAM survey. Data were analyzed with 
mean, standard deviation, and paired t-tests to compare means between pre and posttests. Data 
were analyzed by two methods. The first method was the correct discrimination of a medication 
as AI or non AI. The second method was the analysis of the correct identification of AI 
mechanism of interaction. A paired t-test was utilized to evaluate the difference in means 
between the pretest and the posttest.  
Results 
Demographics 
The majority of participants in the sample were female (n = 43, 89.6%). The age 
distribution ranged from 18-21 years old (M=19.3; SD= 0.56).  Most participants identified as 
Caucasian (n=35, 73%).  The students had a variety of previous medically related experiences. 
The majority of previous experience was cardiopulmonary resuscitation certification (n= 21, 
43.8%). There were 16 missing responses to the question on previous medially related 
experiences; thus demographic data is incomplete for that question. Complete demographic data 
can be found in Appendix D.  
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Nursing Students Knowledge of AI Medications  
 The first aim of this study was to identify nursing students’ knowledge of AI 
medications. The measure of knowledge was determined by the number of correct answers on 
the pretest. Knowledge was assessed by two methods. The first method was the correct 
discrimination if the medication was AI or non-AI. The mean score of correctly identifying 
medications as AI or non-AI was 68.5%, SD= 6.3, range 50%-79%.  The most correctly 
identified medication was hydrocodone (Vicodin) (100%). The least correctly identified 
medication was simvastatin (Zocor) (8.2%). The second method was the correct identification of 
the mechanism of interaction if the medication was AI. The mean pretest score for correct 
identification of the mechanism was 27.5%, SD=14.2, range 0% to 62%. The most correctly 
identified medication for correct AI mechanism of interaction was Ibuprofen (Advil) (49%). The 
least correctly identified medications were prednisone (Deltasone) (4.1%) and simvastatin 
(Zocor) (8.2%), both of which are not AI medications.  
Efficacy of a Single Lecture of AI Medication Content 
The second aim of this study was to identify if a single one-hour lecture was sufficient to 
educate undergraduate nursing students on AI medication content. The measure of AI medication 
content knowledge was determined by the number of correct answers on the posttest. The 
posttest was evaluated by two methods.  
The first method was the ability to discriminate if the medication was AI or non-AI. The 
mean score of correctly identifying medications as AI or non AI was 71.6%, SD=6.6, range 
57%-86%.  The most correctly identified medications were furosemide (100%), metoprolol 
(Lopressor) (100%), and gabapentin (Neurontin) (100%), all of which are AI medications. 
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Hydrocodone (Vicodin) decreased from the pretest score to posttest score (100% vs. 94%; 
t=1.78; p>.05). The least correctly identified medication was prednisone (2.1%). Simvastatin 
(Zocor) increased from pretest score to posttest score (8.2% vs 18.6%; t=1.53; p>.05).  A 
significant increase was found between pretest and posttest scores for several medications. 
Omeprazole (Prilosec) increased 21.2% (14.3% vs 35.4%; t=2.34; p< .05), furosemide (Lasix) 
increased 16.3% (83.3% vs 100%; t=3.07; p<.02), and metoprolol (Lopressor) increased 8.2% 
(91.8% vs 100%; t=2.07; p<.05). A comparison between pretest and posttest correct 
discrimination of AI vs Non AI medication can be found in Table 3 (Appendix E). 
The second method was the percentage of correct responses on the identification of the 
correct mechanism of interaction for an AI medication. The mean posttest score for identification 
of the correct mechanism was 37.3%, SD= 16.6, range 7% to 71%. The most correctly identified 
medication was hydrochlorothiazide (Aquazide H, Hydrocot, Microzide, Zide) (70.8%).  Correct 
identification of ibuprofen (Advil) improved from pretest score to posttest score (49% vs 69%; t 
=2.34; p<.02). The least correctly identified medication was prednisone (Deltasone) which 
decreased from pretest score to posttest (4.1% vs 2.1%; t=.057; p> .05), Simvastatin (Zocor) 
improved from pretest score to posttest score (8.2% vs 18.8%; t=1.53; p>.05). A significant 
increase was found in several medications pretest to posttest score. Metoprolol (Lopressor) had 
44% increase (18.4% vs 62.5%; t=5.23; p < .02), ibuprofen (Advil) had a 19% increase (50% vs 
69%; t= 2.34; p< .02), and hydrochlorothiazide (Aquazide H, Hydrocot, Microzide, Zide) had a 
38.1% increase (32.7% vs 70.8%; t= 3.86; p <.02).  Levothyroxine (Synthroid) had a significant 
decrease from pretest to posttest (31.3% vs 6.30%; t=3.86; p< .02).   A comparison of pretest and 
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posttest scores for each individual medication on the correct identification of the mechanism of 
interaction can be found in Table 2 (Appendix E). 
A significant increase was found between pretest and posttest mean score on correct 
identification of mechanism (27.47 ± 14.18 vs 37.33 ± 16.60; t =3.15; p < .02). A significant 
increase was also found between pretest and posttest mean scores on the ability to discriminate a 
medication as AI or Non-AI (68.5% ± 6.3 vs 71.5% ± 6.5; t= 2.5; p <. 02). A comparison of 
pretest and posttest mean scores can be found in Table 4 (Appendix E). 
Reliability of the JaNKAM  
The third aim of this study was to determine the reliability of the JaNKAM AI 
Medication Survey tool. To determine the reliability of the JaNKAM, internal consistency was 
measured using Cronbach’s alpha. Internal consistency is the degree to which all items on a scale 
measure the same concept (Polit & Beck, 2013). Cronbach’s alpha is a reliability index that is 
used for nominal data that are scored dichotomously (Waltz, Stickland, & Lenz, 2010). 
Cronbach’s alpha is appropriate for the JaNKAM because the survey was scored dichotomously 
in a correct/incorrect fashion. The JaNKAM survey demonstrated a low level of reliability (α = 
0.549) on the posttest.  
Discussion 
 This study examined nursing students’ knowledge of AI medications and if a single one-
hour lecture would be sufficient to increase knowledge. The findings demonstrated that a single 
one-hour lecture was effective in increasing knowledge.  A significant increase was observed in 
both the correct identification of the mechanism of interaction and correct discrimination of AI 
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vs non AI. The students’ ability to identify the correct mechanism was, however, lower than their 
ability to correctly discriminate if a medication was AI or non AI.  
Both alcohol and AI medications are common in today’s society, with 56% of the US 
population 18 and older drinking alcohol on a monthly basis and 41.5% of that population also 
taking an AI medication (Breslow et al., 2015).  Older adults are particularly at risk for AI 
medications and alcohol interactions as 16.2 million adults aged 65 or older reported that they 
drank alcohol in the past month (Mattson, Lipari, Hays& Horn, 2017).  In the US 90.6% of 
adults aged 65 and older reported taking a prescription drug in the last 30 days. Patient safety and 
patient education are both key components of a nurse’s job description and therefore nurses need 
AI medication knowledge in order to do their job effectively. Practicing nurses need both the 
ability to discriminate a medication as AI or non AI, and the ability to correctly identify the 
mechanism. To safely provide patient care and education, professional nurses need knowledge of 
the specific mechanism of interaction and not just possess the ability to discriminate an AI 
medication vs a non AI medication. Patients need to be educated on the specific mechanism of 
action so that the patient can report to a healthcare provider if he/she experiences adverse effects. 
A patient will not know whether they are experiencing an adverse effect of alcohol and the 
medication interacting or if it is an effect of just the medication, without proper education by a 
nurse.  
 To the researchers’ knowledge, no other comparable studies have been conducted in 
undergraduate nursing programs to assess nursing students’ knowledge of AI medications. 
Overall, undergraduate nursing curricula is deficient in AI medication content. The reported 
curricula focus on alcohol abuse, addiction and withdrawal (Mollica, Hyman, & Mann, 2011). 
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Thus, this study is the first to focus on assessment and improvement of undergraduate nursing 
students’ knowledge of AI medications. 
The implications of these findings inform nursing schools’ curricula decisions. The 
findings show that sophomore nursing students are able to learn AI medication content from a 
single one-hour traditional lecture. Based on the pretest vs posttest scores, the students’ 
knowledge was greater when it came to discriminating between AI vs non AI than correctly 
identifying a mechanism of interaction. These findings inform curricular decisions by 
demonstrating a need for increased emphasis in education on the mechanism of interaction of AI 
medication. Undergraduate nursing schools could use these findings to make an informed 
decision on inclusion of AI medication content into the sophomore year curriculum. 
Undergraduate nursing schools can also utilize these findings to evaluate the effectiveness of a 
single traditional one-hour lecture as the method of delivery for AI medication content or if 
another method of instruction could potentially be more beneficial for their specific institution.  
Limitations 
The convenience sample (n=48) was taken from 50 undergraduate sophomore nursing 
majors in a Pathophysiology and Pharmacology course enrolled at a small Midwestern liberal 
arts university. The sample is representative of the study body, at this School of Nursing. Both 
the university demographic profile and the single-site convenience sample of students decreases 
the generalizability of the findings to the entire United States undergraduate nursing student 
population.  The survey had a lower level of reliability (a=0.549), and due to this lower 
reliability the findings from this study need to be interpreted with caution.  The lower reliability 
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of the survey used in this study compared to the survey used in Serafico and Jarvis, (2017) could 
be partially attributable to the smaller amount of questions (14) (Tavakol & Dennick, 2011).  
The traditional one-hour lecture on AI medications was taught by the senior level student 
researcher. The student researcher had no prior training in education methods. The undergraduate 
nursing program that the student researcher attended prepared students to be generalist nurses not 
nurse educators. The student researcher had no prior experience delivering a lecture for 50 
minutes. Due to the lack of experience of the student researcher in education, the students may 
not have learned the AI medication content thoroughly. The experience of the student researcher 
in lecturing is a potential limitation in the study. It cannot be determined without a true 
experimental design to what degree the lecture delivered by the student researcher affected the 
scores of the JaNKAM.  
Certain medications were taught in the N217 Pathophysiology and Pharmacology 
curriculum, by the professor in the time between the pretest and posttest. The following 
medications were taught in between the pretest and posttest: simvastatin (Zocor), 
hydrochlorothiazide (Aquazide H,Hydrocot, Microzide, Zide), ibuprofen (Advil), Lisinopril ( 
Prinivil, Zestril), amlodipine (Norvasc), furosemide (Lasix), metoprolol (Lopressor), and losartan 
(Cozzar). The students improved on their ability to discriminate AI vs non AI on the following 
meds: hydrochlorothiazide (Aquazide H, Hydrocot, Microzide, Zide), ibuprofen (Advil), 
Lisinopril (Prinivil, Zestril), amlodipine (Norvasc), furosemide (Lasix), metoprolol (Lopressor), 
and losartan (Cozzar). The students also improved on their ability to identify the correct 
mechanism of an AI medication for the following meds: simvastatin (Zocor), 
hydrochlorothiazide (Aquazide H, Hydrocot, Microzide, Zide), ibuprofen (Advil), Lisinopril 
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(Prinivl, Zestril), furosemide (Lasix), metoprolol (Lopresor), and losartan (Cozzar). The 
following medications are on the JaNKAM survey, but are taught in spring N218 
Pathophysiology and Pharmacology II not in N217 in the fall: hydrocodone (Vicodin), 
omeprazole (Prilosec), levothyroxine (Synthroid), prednisone (Deltasone), metformin 
(Glucophage), and gabapentin (Neurontin). There was no way to determine if the increase in 
JaNKAM scores was a result of the AI medication lecture alone or if the content delivered in 
N217 Pathophysiology and Pharmacology contributed to the increase. This study was not 
constructed in a true experimental design and therefore that difference is cannot be assessed. The 
knowledge gained in N217 independent of the AI medication lecture could have positively 
affected the students’ scores on those medications. It cannot be determined if the increase in 
ability to discriminate AI vs non AI and the correct identification of the mechanism was due to 
the AI medication lecture, the information presented by the N217 professor, or a combination of 
both.  
Future Research 
The students’ knowledge needs to be assessed longitudinally to determine if retention of 
the knowledge has been achieved. The same posttest administered in this study will be 
administered at the end of the students’ sophomore year (April,2019), in order to assess 
retention. In future research the identical posttest could be administered during the students’ 
junior year and senior year. Effectiveness on the basis of retention of the AI medication lecture 
may be determined based on the posttest scores at each interval. The current findings, due to the 
sample demographics have limited generalizability. To increase the generalizability of the 
findings, other undergraduate nursing programs could be invited to participate in future studies. 
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To address the lower reliability of the JaNKAM survey (α = 0.549), review of each question will 
be undertaken to assess for phrases or words that may mislead participants.  
Conclusion 
A key role of nurses is to be vigilant of health risks, such as AI medications, and provide 
health education accordingly, as defined by The Essentials of Baccalaureate Education for 
Professional Nursing Practice (American Association of Colleges of Nursing, 2008). Current 
undergraduate nursing curricula may be deficient in AI medication content.  Nursing students, 
however, are capable of learning AI medication content, thus preparing them to be safe and 
effective practicing nurses. The results of this study should be interpreted with caution due to the 
limited generalizability due to the small sample size that is non representative of all 
undergraduate nursing students in the United States. Although the results should be interpreted 
with caution, undergraduate nursing programs could utilize these findings and data from future 
studies to make informed curricular decisions.  These findings can be utilized by undergraduate 
nursing schools to determine if and how they want to incorporate AI medication content into 
their curricula.  
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Appendix A 
 
Invitation Asking Participants to Complete Survey & Consent 
Jarvis Survey on Alcohol Interactive Medications 
 
Please participate in a research study on knowledge of prescription medications and alcohol 
drinking. Your responses are important in helping us plan education for students. This study is 
conducted by Dr. Carolyn Jarvis from Illinois Wesleyan University. 
 
This study will take about 15 minutes of your time. You will be asked a few basic demographic 
questions, and questions about specific commonly prescribed medications and their interaction 
with alcohol.  
 
Your decision to participate in this study is completely voluntary and does not count toward you 
course grade. Please answer all the questions. If you do not know an answer, give it your best 
guess.  
 
Your participation in this research will be completely confidential and data will be averaged and 
reported in aggregate. Possible outlets of these data may be conferences and publication in peer-
reviewed journals. Although your participation in this research may not benefit you personally, it 
will help us very much in planning nursing education regarding alcohol-interactive medications 
and patient safety.  
 
The primary risk in this study is loss of confidentiality. But, because no identifiable data are 
being kept, the risk to loss of confidentiality is minimal. All information will be locked and 
remain confidential.   
 
If you have questions about this project, you may contact Carolyn Jarvis, PhD, APRN (309-556-
3297; cjarvis@iwu.edu). If you have any questions about your rights as a participant in this study 
or any concerns or complaints, please contact the Illinois Wesleyan University IRB at 309-556-
3255 or via email at irb@iwu.edu. 
 
By completing this survey, you are consenting to participate in this study. Please ask for a print 
copy of this consent form for your records, if you wish.  
 
Your decision to participate will have no effect on your current status or future relations with 
Illinois Wesleyan University. By completing this survey, you are consenting to participate in this 
study. 
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Appendix B 
 
AI Medications Lecture PowerPoint Slides 
  
  
  
  
ALCOHOL INTERACTIVE MEDICATIONS 28 
  
  
  
  
ALCOHOL INTERACTIVE MEDICATIONS 29 
   
   
 
  
ALCOHOL INTERACTIVE MEDICATIONS 30 
Appendix C 
Survey Tool: Jarvis Nursing Knowledge of AI Medications (JaNKAM) Survey 
1. Please fill in your student ID number  
 
2. What gender? 
• Female 
• Male 
• Transgender 
      3. Age in years 
 
 4. Have you had any of the following 
• CAN 
• CPR 
• EMT 
• Phlebotomist 
• Other medical experience 
5. With what ethnic origin do you affiliate? 
• African American 
• Asian 
• Caucasian 
• Latino/a 
• Other 
 
Each question below will identify a common medication given in the hospital or outpatient 
setting. Assume the patient drinks 1-2 standard alcohol drinks per day.  Please look at each 
medication and answer the way it interacts with alcohol. Please do not use any device or 
book references as you answer these questions. We just want to learn a baseline for nursing 
education. It is OK if you do not know an answer. 
 
6. How do Hydrocodone/Acetaminophen (Lortab, Vicodin, Norco) and alcohol 
interact? 
• Both substances cause respiratory depression and sleepiness 
• Both substances cause high blood pressure crisis 
• Both substances cause kidney toxicity 
• Alcohol decreases pain relief of hydrocodone/acetaminophen 
• Hydrocodone/acetaminophen and alcohol do not interact 
 
7. How do simvastatin (Zocor) and alcohol interact? 
• Both substances increase risk of heart attack 
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• Both substances increase risk of diabetes 
• Alcohol causes high blood cholesterol and cancels statin benefits 
• Both substances increase risk of myopathy 
• Simvastatin and alcohol do not interact 
 
8. How does hydrochlorothiazide (HCTZ, Hydrocot) and alcohol interact? 
• Both substances increase risk of peripheral edema 
• Both substances increase risk of hearing loss 
• Both substances increase risk of enlarged breasts in men and menstrual irregularities 
in women 
• Both substances decrease blood pressure 
• Hydrochlorothiazide and alcohol do not interact 
 
9. How do omeprazole (Prilosec) and alcohol interact? 
• Both substances increase risk of pneumonia 
• Both substances increase risk of osteoporosis and fractures 
• Both substances increase risk of intestinal infection with Clostridium difficile 
• Alcohol increases risk of acid rebound when stopping omeprazole 
• Omeprazole and alcohol do not interact 
 
10.  How do ibuprophen (Advil) and alcohol interact? 
• Both substances Increase risk of edema 
• Both substances Increase risk for bleeding 
• Both substances Increase risk of kidney toxicity 
• Both substances increase risk of high blood potassium 
• Ibuprophen and alcohol do not interact 
 
11.  How do levothyroxine Levoxyl, Synthroid) and alcohol interact? 
• Alcohol reduces levothyroxine absorption 
• Alcohol increases levothyroxine metabolism 
• Both substances increase risk of myxedema coma 
• Both substances increase risk of simple goiter 
• Levothyroxine and alcohol do not interact 
 
12.  How do lisinopril (Zestril, Prinivil) and alcohol interact? 
• Both substances increase risk of edema of tongue, lips or eyelids 
• Both substances decrease blood pressure 
• Both substances increase risk of cough 
• Both substances increase risk of high blood potassium 
• Lisinopril and alcohol do not interact 
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13.  How do amlodipine (Norvasc) and alcohol interact? 
• Both substances increase risk of headache 
• Both substances increase risk of peripheral edema 
• Both substances increase risk of constipation 
• Both substances decreased blood pressure 
• Amlodipine and alcohol do not interact 
 
14.  How do furosemide (Lasix) and alcohol interact? 
• Both substances decrease blood pressure 
• Both substances increase risk of potassium loss 
• Both substances increase risk of hearing loss 
• Alcohol stops the diuretic effect of furosemide 
• Furosemide and alcohol do not interact 
 
15.  How do prednisone and alcohol interact? 
• Both substances suppress the adrenal glands 
• Both substances increase risk of fungal infection 
• Both substances increase physiologic stress 
• Alcohol speeds up glucocorticoid withdrawal 
• Prednisone and alcohol do not interact 
 
16.  How do metformin (Glucophage) and alcohol interact? 
• Both substances decrease appetite and cause nausea and vomiting 
• Both substances cause weight gain 
• Both substances allow buildup of lactic acid in the blood 
• Both substances increase risk of acute kidney failure 
• Metformin and alcohol do not interact 
 
17.  How do gabapentin (Neurontin) and alcohol interact? 
• Both substances cause dizziness and sleepiness 
• Both substances increase risk for headache 
• Both substances increase risk for peripheral edema 
• Both substances cause blurred vision 
• Gabapentin and alcohol do not interact 
 
18.  How do metoprolol (Lopressor) and alcohol interact? 
• Both substances increase risk of hyperthyroidism 
• Both substances cause constriction of breathing tubes 
• Both substances decrease blood pressure 
• Both substances increase the risk of migraine headaches 
• Metoprolol and alcohol do not interact 
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19.  How do losartan (Cozaar) and alcohol interact 
• Both substances cause swelling of the lips, tongue or eyelids 
• Both substances decrease blood pressure 
• Both substances cause kidney failure 
• Both substances increase levels of potassium in the blood 
• Losartan and alcohol do not interact 
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Appendix D 
Table 1: Demographic Characteristics of Participants of Posttest (Sex, Age, Ethnicity, Prior Experience) 
Variable  % of total sample 
Sex  
Male  10.40 
Female 89.60 
Ethnicity  
African American  6.30 
Asian  6.30 
Caucasian 72.90 
Latino/a 29.20 
Age  
18  2.10 
19  75.00 
20 18.80 
21  4.20 
Prior Experience  
CNA 14.5 
CPR 52.1 
EMT  2.0 
Phlebotomist 2.0  
Missing data  29.2 
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Appendix E 
Table 2: Comparison of Pretest and Posttest Correct ID of Mechanism of Interaction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
  *p < .05 
Medication Pretest Posttest t(p) 
amlodipine 24.5% 24% 0.26(0.80) 
furosemide 14.6% 31.6% 1.8(0.07) 
gabapentin 35.4% 50.0% 1.5(0.13) 
hydrochlorothiazide 32.7% 70.8% 3.9(0.0003)** 
hydrocodone 34.7% 50.0% 1.4(0.16) 
ibuprofen 50.0% 69.0% 2.3(0.03)* 
lisinopril 34.7% 42.6% 0.62(0.54) 
levothyroxine 31.3% 6.30% 3.3(0.002)** 
losartan 20.4% 29.2% 0.94(0.35) 
metformin 20.4% 34.0% 1.4(0.16) 
metoprolol 18.4% 62.5% 5.2(0.0001)** 
omeprazole 36.7% 31.3% 0.55(0.58) 
prednisone 4.1% 2.1% 0.57(0.57) 
simvastatin 8.2% 18.8% 1.5(0.13) 
**p < .02 
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Table 3: Comparison of pretest and Posttest discrimination of AI vs Non AI score 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
*p < .05 
 
 
 
 
Medication Pretest Posttest t(p) 
amlodipine 91.8% 93.5% 0.37(0.71) 
furosemide 83.3% 100% 3.07(0.004)** 
gabapentin 97.9% 100% 1.00(0.32) 
hydrochlorothiazide 87.8% 95.8% 1.66(0.10) 
hydrocodone 100% 93.8% 1.77(0.08) 
ibuprofen 83.7% 89.6% 0.90(0.37) 
lisinopril 95.9% 93.6% 0.44(0.66) 
levothyroxine 6.3% 6.3% 0.00(1.00) 
losartan 95.9% 83.3% 2.21(0.03)* 
metformin 98.0% 89.4% 2.07(0.04)* 
metoprolol 91.8% 100% 2.07(0.04)* 
omeprazole 14.3% 35.4% 2.34(0.02)* 
prednisone 4.1% 2.1% 0.57(.057) 
simvastatin 8.2% 18.8% 1.53(0.13) 
**p < .02 
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Table 4: Comparison of Pretest and Posttest JaNKAM score 
 
 
 
 
*p < .02 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Statistic Pretest Posttest t(p) 
AI or Non AI 68.5% ± 6.3 71.5% ± 6.5 2.5(0.02)* 
Correct mechanism ID 27.3% ± 14.2 37.3% ± 16.6 3.15 (0.003) * 
